16 Hrs
Source:
الصباح
الصباح
Ready to play
Ready to play
Russian scientists have developed an innovative treatment for hepatitis B, utilizing the CRISPR/Cas9 gene editing technology to target and remove the virus's genetic material within infected cells. This approach enhances the chances of complete recovery and reduces the likelihood of disease recurrence. A delivery system has been designed using biodegradable nanoparticles that can directly transport the therapeutic compounds to liver cells, showing promising results in laboratory experiments and preclinical studies. Currently, researchers are working to complete the research phase in preparation for clinical trials on humans.
Notice: This Is an AI-Generated Summary
Comments (0)